48 Stocks Moving In Friday’s Mid-Day Session
Gainers
Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ADS.
Mid-Morning Market Update: Markets Down; Nasdaq Falls 100 Points
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Friday.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 581 stocks hit new 52-week lows.
Interesting Highlights From Today's 52-Week Lows
Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
HC Wainwright Sees ‘Multiple Catalyst Opportunities’ After Atreca Inks Licensing Pact With Zymeworks
Atreca Inc (NASDAQ:BCEL) announced a licensing agreement with Zymeworks Inc (NYSE:ZYME) to utilize their ZymeLink technology to develop novel antibody-drug conjugates (ADCs). The…
Zymeworks: Q4 Earnings Insights
Zymeworks (NYSE:ZYME) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Zymeworks beat estimated earnings by 16.67%, reporting an EPS of $-0.95 versus an estimate of $-1.14.
